Kan vi stole på producentsponsorerede studier?

Davidson RA. Source of funding and outcome of clinical trials. J Gen Intern Med 1986;1:155-8.
Bero LA, Galbraith A, Rennie D. The publication of sponsored symposiums in medical journals. N Engl J Med 1992;327:1135-40.
Rochon PA, et al. Evaluating the quality of articles published in journal supplements compared with the quality of those published in the parent journal. JAMA 1994;272:108-13.
Rochon PA, et al. A study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis. Arch Intern Med 1994;154:157-63.
Cho MK, Bero LA. The quality of drug studies published in symposium proceedings. Ann Intern Med 1996;124:485-9.
Bero LA, Rennie D.Influences on the quality of published drug studies. Int J Technol Assess Health Care. 1996;12(2):209-237
Friedberg M, et al. Evaluation of conflict of interest in economic analyses of new drugs used in oncology. JAMA1999:282:1453-7.
Choudhry NK, Stelfox HT, Detsky AS. Relationships between authors of clinical practice guidelines and the pharmaceutical industry. JAMA 2002;287:612-617.
Bekelman JE, Li Y, Gross CP. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA. 2003 Jan 22-29;289(4):454-65.
Als-Nielsen B, Chen W, Gluud C, Kjaergard LL. Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events? JAMA. 2003 Aug 20;290(7):921-8.
Lexchin J, Bero LA, Djulbegovic B, Clark O.Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ. 2003;326(7400):1167-1170
Finucane TE, Boult CE. Association of funding and findings of pharmaceutical research at a meeting of a medical professional society.Am J Med. 2004 Dec 1;117(11):842-5.
Brown A, Kraft D, Schmitz SM, Sharpless V, Martin C, Shah R, Shaheen NJ. Association of industry sponsorship to published outcomes in gastrointestinal clinical research. Clin Gastroenterol Hepatol. 2006 Dec;4(12):1445-51.
Lynch JR, Cunningham MR, Warme WJ, Schaad DC, Wolf FM, Leopold SS.Commercially funded and United States-based research is more likely to be published; good-quality studies with negative outcomes are not. J Bone Joint Surg Am. 2007 May;89(5):1010-8.
Sismondo S.Pharmaceutical company funding and its consequences: a qualitative systematic review.Contemp Clin Trials. 2008;29(2):109-113
McGauran N, Wieseler B, Kreis J, Schüler YB, Kölsch H, Kaiser T. Reporting bias in medical research – a narrative review. Trials. 2010 Apr 13;11:37.
Fugh-Berman A, McDonald CP, Bell AM, Bethards EC, Scialli AR. Promotional tone in reviews of menopausal hormone therapy after the Women’s Health Initiative: an analysis of published articles. PLoS Med. 2011 Mar;8(3):e1000425
Roseman M, Milette K, Bero LA, et al. Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments.JAMA. 2011;305(10):1008-1017
Becker A, Dörter F, Eckhardt K, Viniol A, Baum E, Kochen MM, Lexchin J, Wegscheider K, Donner-Banzhoff N. The association between a journal’s source of revenue and the drug recommendations made in the articles it publishes. CMAJ. 2011 Mar 22;183(5):544-8
Lundh A, Krogsbøll LT, Gøtzsche PC. Sponsors’ participation in conduct and reporting of industry trials: a descriptive study. Trials. 2012 Aug 24; 13:146
Lee YK, Chung CY, Koo KH, Lee KM, Ji HM, Park MS. Conflict of interest in the assessment of thromboprophylaxis after total joint arthroplasty: a systematic review. J Bone Joint Surg Am. 2012 Jan 4;94(1):27-33.
Lexchin J.Those who have the gold make the evidence: how the pharmaceutical industry biases the outcomes of clinical trials of medications. Sci Eng Ethics. 2012;18(2):247-261
Lundh A, Sismondo S, Lexchin J, Busuioc OA, Bero L. Industry sponsorship and research outcome. Cochrane Database Syst Rev. 2012 Dec 12
Bero, LA. Industry Sponsorship and Research Outcome – A Cochrane Review. JAMA Intern Med. 2013;():1-2. ONLINE FIRST doi:10.1001/jamainternmed.2013.4190
Sung KH, Chung CY, Lee KM, Lee YK, Lee SY, Lee J, Choi IH, Cho TJ, Yoo WJ, Park MS. Conflict of interest in the assessment of botulinum toxin A injections in patients with cerebral palsy: a systematic review. J Pediatr Orthop. 2013 Jul-Aug;33(5):494-500.
Amiri AR, Kanesalingam K, Cro S, Casey AT. Does source of funding and conflict of interest influence the outcome and quality of spinal research?Spine J. 2014 Feb 1;14(2):308-14. doi: 10.1016/j.spinee.2013.10.047. Epub 2013 Nov 12.
Dunn AG, Arachi D, Hudgins J, Tsafnat G, Coiera E, Bourgeois FT. Financial conflicts of interest and conclusions about neuraminidase inhibitors for influenza: an analysis of systematic reviews. Ann Intern Med. 2014 Oct 7;161(7):513-8.